High neutrophil-to-lymphocyte ratio before starting anti-programmed cell death 1 immunotherapy predicts poor outcome in patients with metastatic melanoma

Publication date: July 2018

Source: Journal of the American Academy of Dermatology, Volume 79, Issue 1

Author(s): Margaux Garnier, Julia Zaragoza, Nathalie Bénéton, Guido Bens, Victoire Meurisse, Mahtab Samimi, Hervé Maillard, Laurent Machet

https://ift.tt/2KPj3fV